Correlation Engine 2.0
Clear Search sequence regions


  • apoptosis (2)
  • ATP1A1 (11)
  • atp1a1 protein human (1)
  • BCL2 (1)
  • cell cycle (1)
  • cell death (1)
  • colon cancer (6)
  • EGFR (1)
  • ERK5 (2)
  • human (2)
  • MAP2K5 (1)
  • mitogen (1)
  • MYC (1)
  • patients (3)
  • prognostic (1)
  • protein human (1)
  • regulates (1)
  • rna (1)
  • subunit (1)
  • t stage (1)
  • Sizes of these terms reflect their relevance to your search.

    Na+/K+-ATPase α1 subunit (ATP1A1) exhibits aberrant expression in various types of cancer. Moreover, its levels in specific tissues are associated with the development of cancer. Nevertheless, the mechanism and signaling pathways underlying the effects of ATP1A1 in colon cancer (CC) have not been elucidated, and its prognostic impact remains unknown. Knockdown of ATP1A1 expression was performed in human CC cell lines HT29 and Caco2 using small interfering RNA. The roles of ATP1A1 in various biological processes of cells (i.e., proliferation, cell cycle, apoptosis, migration, and invasion) were assessed. Microarray analysis was utilized for gene expression profiling. Samples obtained from 200 patients with CC who underwent curative colectomy were analyzed through immunohistochemistry. ATP1A1 knockdown suppressed cell proliferation, migration, and invasion and induced apoptosis. The results of the microarray analysis revealed that the upregulated or downregulated gene expression in ATP1A1-depleted cells was related to the extracellular signal-regulated kinase 5 (ERK5) signaling pathway [epidermal growth factor receptor (EGFR), mitogen-activated protein kinase kinase 5 (MAP2K5), mitogen-activated protein kinase 7 (MAPK7), FOS, MYC, and BCL2 associated agonist of cell death (BAD)]. Immunohistochemical analysis demonstrated a correlation between ATP1A1 expression and pathological T stage (p = 0.0054), and multivariate analysis identified high ATP1A1 expression as an independent predictor of poor recurrence-free survival in patients with CC (p = 0.0040, hazard ratio: 2.807, 95% confidence interval 1.376-6.196). ATP1A1 regulates tumor progression through the ERK5 signaling pathway. High ATP1A1 expression is associated with poor long-term outcomes in patients with CC. © 2023. Society of Surgical Oncology.

    Citation

    Shutaro Sumiyoshi, Atsushi Shiozaki, Toshiyuki Kosuga, Hiroki Simizu, Michihiro Kudo, Jun Kiuchi, Tomohiro Arita, Hirotaka Konishi, Shuhei Komatsu, Yoshiaki Kuriu, Takeshi Kubota, Hitoshi Fujiwara, Yukiko Morinaga, Eiichi Konishi, Eigo Otsuji. Functional Analysis and Clinical Importance of ATP1A1 in Colon Cancer. Annals of surgical oncology. 2023 Oct;30(11):6898-6910

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 37407874

    View Full Text